Sector News

Haemonetics appoints Bill Burke CFO

August 1, 2016
Life sciences

Haemonetics Corporation today announced that William P. Burke will join the Company as Chief Financial Officer, effective August 8, 2016. In this role, he will oversee the Company’s treasury, controllership and accounting, investor relations, tax and financial planning and analysis functions.

Mr. Burke will join the Company directly from Medtronic, Inc. where he has served as Chief Integration Officer for the integration of Covidien into Medtronic since June 2015, filling the key role of principal operating officer for the integration management office. Previously, he held various Finance positions of increasing responsibility over a 20-year career with Covidien and predecessor companies, including CFO – Europe, Vice President of Corporate Strategy and Portfolio Management, and Vice President of Financial Planning and Analysis.

Christopher Simon, Haemonetics’ CEO, stated: “Bill Burke is a valuable addition to our team at an important point in time. He is a thoughtful, pragmatic leader with a strong background in all elements of strategy and finance, deep knowledge of the medical device industry and a proven ability to build strong teams that deliver peak performance amid complex change.”

Source: Haemonetics

comments closed

Related News

September 25, 2022

Rise of the machines: Novo Nordisk pledges $200M to create first quantum computer for life sciences

Life sciences

Big Pharma has long seen the potential for AI and machine learning to accelerate drug development. But Novo Nordisk is going a step further by channeling $200 million toward the creation of a computer that will outrun anything in existence.

September 25, 2022

Mount Sinai AI uncovers new brain analysis method to predict dementia, Alzheimer’s disease

Life sciences

Current methods for diagnosing Alzheimer’s disease rely on a complex combination of self- and caregiver-reported symptoms, a physical examination and either a PET scan or a spinal tap to look for evidence of amyloid plaque build-ups in the brain. But a new artificial intelligence-based method may make the diagnostic process a much more objective one.

September 25, 2022

New AstraZeneca-backed report finds big money behind diverse owners and entrepreneurs in Europe

Life sciences

There is lots of talk about diversity and inclusion in business, including in pharma and medtech. A new report by the Open Political Economy Network (OPEN), a think tank focusing on migration and diversity, released its “Minority Businesses Matter: Europe” report highlighting the successes and challenges of ethnic minority-owned businesses in Europe.